Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-003344-62Phase 4Completed
Phase 4 trial of theophylline and fluticasone in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by Imperial College London. Primary endpoint: Sputum inflammatory cell counts. Started Oct 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-003344-62.